| Ovarian cancer as a genetic disease . | |
| | |
MedLine Citation:
|
PMID: 23276941 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Ovarian cancer is characterized by the highest mortality rate among gynecologic malignancies. Therefore, there is a growing need for innovative therapies and techniques for monitoring and prevention of this disease. The exact cause of most ovarian tumors usually remains unknown. Ovarian cancer is believed to be caused by a range of different variables. This review is an attempt to summarize some genetic factors involved in the disruption of certain signaling pathways responsible for ovarian tumor transformation and development. Those factors considerably contribute to accurate diagnostics, treatment and prognosis in ovarian cancer. |
| | |
Authors:
|
Agnieszka Lech; Teodora Daneva; Shina Pashova; Hristo Gagov; Robert Crayton; Wojciech Kukwa; Anna M Czarnecka; Cezary Szczylik |
Publication Detail:
|
Type: Journal Article Date: 2013-01-01 |
Journal Detail:
|
Title: Frontiers in bioscience : a journal and virtual library Volume: 18 ISSN: 1093-4715 ISO Abbreviation: Front. Biosci. Publication Date: 2013 |
Date Detail:
|
Created Date: 2013-01-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9709506 Medline TA: Front Biosci Country: United States |
Other Details:
|
Languages: eng Pagination: 543-63 Citation Subset: IM |
Affiliation:
|
Department of Oncology, Military Institute of Medicine, Szaserow 128, 04-141 Warsaw, Poland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Molecular markers of response and resistance to EGFR inhibitors in head and neck cancers .
Next Document: Biomarker discovery by plasma proteomics in familial Brugada Syndrome .